Skip to main content

Table 4 Final regression models (SF 36 domains)

From: Factors associated with health-related quality of life in renal transplant recipients: results of a national survey in France

Dimensions Variables β coeff. 95% CI P values
PF R2 = 0.31 Intercept 95.4 [91.1; 99.6] p < .0001
  Female -4.7 [-7.6; -1.7] p < 0.0018
  Age ≥ 75 years -23.3 [-30.4; -16.2] p < .0001
  Low educational (primary or less) -7.5 [-11.2; -3.8] p < .0001
  Unemployment -6.3 [-9.4; -3.2] p < .0001
  BMI > 30 (kg/m2) -5.8 [-10; -1.6] p < 0.0065
  Critical illness in the last 4 weeks -8.0 [-14.9; -1.1] p < 0.0237
  Diabetes -5.6 [-10.1; -1] p < 0.0163
  Side effects related to general health -17.0 [-20.9; -13.1] p < .0001
  Side effects related to mental health -6.8 [-10.5; -3] p < 0.0004
  Recent surgery -9.5 [-24.9; 6] p < 0.2283
  Infectious disease in the last 4 weeks -4.8 [-9.1; -0.4] p < 0.0311
RP R2 = 0.22 Intercept 90.5 [82.8; 98.1] p < .0001
  Female -6.9 [-12.2; -1.6] p < 0.0104
  Age ≥ 75 years -20.1 [-33.1; -7] p < 0.0026
  Low educational (primary or less) -11.4 [-18; -4.8] p < 0.0007
  Hospitalization in the last 4 weeks -17.9 [-27.1; -8.8] p < 0.0001
  Critical illness in the last 4 weeks -31.5 [-44.8; -18.1] p < .0001
  Infectious disease in the last 4 weeks -10.9 [-19; -2.9] p < 0.0080
  Side effects related to general health -21.5 [-28.7; -14.3] p < .0001
  Side effects related to mental health -16.0 [-22.8; -9.1] p < .0001
BP R2 = 0.23 Intercept 85.3 [80.6; 90] p < .0001
  Female -4.9 [-8.1; -1.6] p < 0.0035
  Age ≥ 75 years -8.3 [-16.1; -0.4] p < 0.0402
  Low educational (primary or less) -6.5 [-10.5; -2.5] p < 0.0016
  Infectious disease in the last 4 weeks -9.1 [-14; -4.3] p < 0.0002
  Side effects related to general health -18.7 [-23.2; -14.2] p < .0001
  Side effects related to mental health -9.7 [-14; -5.4] p < .0001
  Side effects related to body modification -4.2 [-7.7; -0.7] p < 0.0193
MH R2 = 0.24 Intercept 81.1 [77.7; 84.6] p < .0001
  Female -5.6 [-8; -3.3] p < .0001
  Family status (living alone) -4.6 [-7.2; -1.9] p < 0.0007
  Duration of dialysis > 3 years -3.3 [-5.8; -0.8] p < 0.0087
  Hospitalization in the last 4 weeks -7.7 [-11.4; -4] p < .0001
  Side effects related to mental health -16.5 [-19.5; -13.5] p < .0001
  Side effects related to body modification -4.4 [-6.9; -1.9] p < 0.0005
RE R2 = 0.18 Intercept 94.8 [86.5; 103] p < .0001
  Female -6.4 [-12; -0.8] p < 0.0252
  Low educational (primary or less) -16.8 [-24; -9.6] p < .0001
  Age ≥ 75 years -11.1 [-25.3; 3.2] p < 0.1285
  Family status (living alone) -9.1 [-15.3; -2.8] p < 0.0045
  Hospitalization in the last 4 weeks -17.4 [-26.7; -8.1] p < 0.0003
  Infectious disease in the last 4 weeks -19.1 [-27.6; -10.7] p < .0001
  Side effects related to mental health -25.0 [-32; -18.1] p < .0001
SF R2 = 0.25 Intercept 90.8 [86.8; 94.8] p < .0001
  Female -4.9 [-7.6; -2.1] p < 0.0006
  Family status (living alone) -4.6 [-7.8; -1.5] p < 0.0036
  Hospitalization in the last 4 weeks -11.8 [-16.2; -7.3] p < .0001
  Infectious disease in the last 4 weeks -7.2 [-11.5; -2.9] p < 0.0011
  Diabetes -7.5 [-11.5; -3.5] p < 0.0002
  Side effects related to general health -11.3 [-15; -7.6] p < .0001
  Side effects related to mental health -16.4 [-20; -12.8] p < .0001
VT R2 = 0.22 Intercept 62.8 [59.6; 66.1] p < .0001
  Female -2.4 [-4.6; -0.1] p < 0.0366
  Hospitalization in the last 4 weeks -8.3 [-11.8; -4.8] p < .0001
  Side effects related to general health -12 [-15; -8.9] p < .0001
  Side effects related to mental health -11.7 [-14.8; -8.7] p < .0001
  Side effects related to body modification -3.9 [-6.3; -1.4] p < 0.0020
GH R2 = 0.18 Intercept 63.8 [62.1; 65.5] p < .0001
  Hospitalization in the last 4 weeks -6.1 [-10.2; -2] p < 0.0038
  Critical illness in the last 4 weeks -7.1 [-13.5; -0.7] p < 0.0305
  Diabetes -5.4 [-9; -1.7] p < 0.0038
  Side effects related to general health -11.6 [-15.1; -8.1] p < .0001
  Side effects related to mental health -7.7 [-11.1; -4.2] p < .0001
  Side effects related to body modification -5.6 [-8.4; -2.9] p < .0001
  Non-compliant -6.3 [-9.2; -3.4] p < .0001
PCS (R2 = 0.28) Intercept 52.7 [50.9; 54.5] p < .0001
  Female -1.7 [-3; -0.4] p < 0.0084
  Age ≥ 75 years -7.7 [-11; -4.3] p < .0001
  Low educational (primary or less) -3.3 [-4.9; -1.7] p < .0001
  Unemployment -2.5 [-3.8; -1.1] p < 0.0003
  Critical illness in the last 4 weeks -5.7 [-8.8; -2.6] p < 0.0003
  Infectious disease in the last 4 weeks -3.2 [-5.1; -1.3] p < 0.0012
  Side effects related to general health -9.2 [-10.8; -7.5] p < .0001
MCS (R2 = 0.22) Intercept 52.1 [50.3; 54] p < .0001
  Female -1.7 [-3; -0.4] p < 0.0113
  Family status (living alone) -2.2 [-3.7; -0.7] p < 0.0039
  Hospitalization in the last 4 weeks -5.7 [-7.8; -3.6] p < .0001
  Side effects related to body modification -2.5 [-3.9; -1.1] p < 0.0005
  Side effects related to mental health -9.3 [-11; -7.7] p < .0001